International audienceTransjugular intrahepatic portosystemic shunt (TIPS) is an effective treatment for refractory ascites, upper gastrointestinal bleeding, or hepatorenal syndrome in liver transplant candidates.
Complications of portal hypertension are the Achilles heel of end-stage liver disease. Although init...
December 1991 through November 1993, fifty-five patients underwent TIPS with the following indicatio...
Chylous ascites (CA) is the extravasation of lipid-rich lymphatic fluid into the peritoneal space fo...
BACKGROUND/AIMS: TIPS (transjugular intrahepatic portosystemic stent-shunt) has been used increasing...
Background/Aims: TIPS (transjugular intrahepatic portosystemic stent-shunt) has been used increasing...
Transjugular intrahepatic portosystemic stent shunting (TIPSS) appears to be an attractive, nonsurgi...
Transjugular intrahepatic portosystemic shunt (TIPS) is a non-operative therapeutic option for the m...
A 39-year-old female, liver transplanted for Autosomic Dominant Polycystic Kidney Disease (ADPKD) de...
AbstractChylous ascites (CA) is the extravasation of lipid-rich lymphatic fluid into the peritoneal ...
Transjugular intrahepatic portosystemic shunt (TIPS) represents a very effective treatment of compli...
The transjugular intrahepatic portosystemic shunt (TIPS) represents a major advance in the treatment...
Background: Transjugular intrahepatic portosys-temic shunts (TIPS) have been used to control symp-to...
Transjugular intrahepatic portosystemic shunt (TIPS) is adopted to treat refractory complications of...
Background & AimsThere is controversy over the ability of transjugular intrahepatic portosystemic sh...
Background: Transjugular intrahepatic portosystemic stent shunts (TIPSS) have been used successfully...
Complications of portal hypertension are the Achilles heel of end-stage liver disease. Although init...
December 1991 through November 1993, fifty-five patients underwent TIPS with the following indicatio...
Chylous ascites (CA) is the extravasation of lipid-rich lymphatic fluid into the peritoneal space fo...
BACKGROUND/AIMS: TIPS (transjugular intrahepatic portosystemic stent-shunt) has been used increasing...
Background/Aims: TIPS (transjugular intrahepatic portosystemic stent-shunt) has been used increasing...
Transjugular intrahepatic portosystemic stent shunting (TIPSS) appears to be an attractive, nonsurgi...
Transjugular intrahepatic portosystemic shunt (TIPS) is a non-operative therapeutic option for the m...
A 39-year-old female, liver transplanted for Autosomic Dominant Polycystic Kidney Disease (ADPKD) de...
AbstractChylous ascites (CA) is the extravasation of lipid-rich lymphatic fluid into the peritoneal ...
Transjugular intrahepatic portosystemic shunt (TIPS) represents a very effective treatment of compli...
The transjugular intrahepatic portosystemic shunt (TIPS) represents a major advance in the treatment...
Background: Transjugular intrahepatic portosys-temic shunts (TIPS) have been used to control symp-to...
Transjugular intrahepatic portosystemic shunt (TIPS) is adopted to treat refractory complications of...
Background & AimsThere is controversy over the ability of transjugular intrahepatic portosystemic sh...
Background: Transjugular intrahepatic portosystemic stent shunts (TIPSS) have been used successfully...
Complications of portal hypertension are the Achilles heel of end-stage liver disease. Although init...
December 1991 through November 1993, fifty-five patients underwent TIPS with the following indicatio...
Chylous ascites (CA) is the extravasation of lipid-rich lymphatic fluid into the peritoneal space fo...
DOI
Add to ORKG